Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer

Yu Chi Chen, Donna M. Sosnoski, Ujjawal H. Gandhi, Leah J. Novinger, K. Sandeep Prabhu, Andrea M. Mastro

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Breast cancer frequently metastasizes to the skeleton resulting in bone degradation due to osteoclast activation. Metastases also downregulate differentiation and the bone-rebuilding function of osteoblasts. Moreover, cancer cells trigger osteoblast inflammatory stress responses. Pro-inflammatory mediators such as interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), expressed by osteoblasts (MC3T3-E1) stimulated with human breast cancer cell (MDA-MB-231) conditioned medium, are pivotal to osteoclast activation and metastasis. Given that these genes are regulated by nuclear factor-κB (NF-κB), a redox-sensitive transcription factor, we hypothesized that selenium (Se) could abrogate the inflammatory response to metastatic breast cancer cells by modulating NF-κB. Caffeic acid phenethyl ester and parthenolide inhibited NF-κB activation, as seen by gel shift assays and immunoblotting for p65 in nuclear fractions, as well as decreased production of IL-6 and MCP-1. Supplementation of MC3T3-E1 with methylseleninic acid (MSA) (0.5 μM to 4 μM) reduced the activation of NF-κB leading to a decrease in IL-6, MCP-1, COX-2 and iNOS in response to MDA-MB-231 conditioned medium. Addition of MSA to osteoblasts for as little as 15 min suppressed activation of NF-κB suggesting that short-lived active metabolites might be involved. However, brief exposure to MSA also brought about an increase in selenoprotein glutathione peroxidase 1. In summary, our data indicate that the osteoblast response to metastatic breast cancer cells is regulated by NF-κB activation, which can be effectively suppressed by MSA either through short-lived active metabolites and/or selenoproteins. Thus, Se supplementation may prevent the osteoblast inflammatory response or dampen the vicious cycle established when breast cancer cells, osteoblasts and osteoclasts interact.

Original languageEnglish (US)
Pages (from-to)1941-1948
Number of pages8
JournalCarcinogenesis
Volume30
Issue number11
DOIs
StatePublished - Dec 4 2009

Fingerprint

Selenium
Osteoblasts
Breast Neoplasms
Bone and Bones
Chemokine CCL2
Osteoclasts
Selenoproteins
Interleukin-6
Nitric Oxide Synthase Type II
Cyclooxygenase 2
Conditioned Culture Medium
Neoplasm Metastasis
Immunoblotting
Skeleton
Oxidation-Reduction
Transcription Factors
Down-Regulation
Gels
methylselenic acid
Genes

All Science Journal Classification (ASJC) codes

  • Cancer Research

Cite this

Chen, Y. C., Sosnoski, D. M., Gandhi, U. H., Novinger, L. J., Prabhu, K. S., & Mastro, A. M. (2009). Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer. Carcinogenesis, 30(11), 1941-1948. https://doi.org/10.1093/carcin/bgp227
Chen, Yu Chi ; Sosnoski, Donna M. ; Gandhi, Ujjawal H. ; Novinger, Leah J. ; Prabhu, K. Sandeep ; Mastro, Andrea M. / Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer. In: Carcinogenesis. 2009 ; Vol. 30, No. 11. pp. 1941-1948.
@article{70fc39ef5ffe4784a02751d2301b2c23,
title = "Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer",
abstract = "Breast cancer frequently metastasizes to the skeleton resulting in bone degradation due to osteoclast activation. Metastases also downregulate differentiation and the bone-rebuilding function of osteoblasts. Moreover, cancer cells trigger osteoblast inflammatory stress responses. Pro-inflammatory mediators such as interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), expressed by osteoblasts (MC3T3-E1) stimulated with human breast cancer cell (MDA-MB-231) conditioned medium, are pivotal to osteoclast activation and metastasis. Given that these genes are regulated by nuclear factor-κB (NF-κB), a redox-sensitive transcription factor, we hypothesized that selenium (Se) could abrogate the inflammatory response to metastatic breast cancer cells by modulating NF-κB. Caffeic acid phenethyl ester and parthenolide inhibited NF-κB activation, as seen by gel shift assays and immunoblotting for p65 in nuclear fractions, as well as decreased production of IL-6 and MCP-1. Supplementation of MC3T3-E1 with methylseleninic acid (MSA) (0.5 μM to 4 μM) reduced the activation of NF-κB leading to a decrease in IL-6, MCP-1, COX-2 and iNOS in response to MDA-MB-231 conditioned medium. Addition of MSA to osteoblasts for as little as 15 min suppressed activation of NF-κB suggesting that short-lived active metabolites might be involved. However, brief exposure to MSA also brought about an increase in selenoprotein glutathione peroxidase 1. In summary, our data indicate that the osteoblast response to metastatic breast cancer cells is regulated by NF-κB activation, which can be effectively suppressed by MSA either through short-lived active metabolites and/or selenoproteins. Thus, Se supplementation may prevent the osteoblast inflammatory response or dampen the vicious cycle established when breast cancer cells, osteoblasts and osteoclasts interact.",
author = "Chen, {Yu Chi} and Sosnoski, {Donna M.} and Gandhi, {Ujjawal H.} and Novinger, {Leah J.} and Prabhu, {K. Sandeep} and Mastro, {Andrea M.}",
year = "2009",
month = "12",
day = "4",
doi = "10.1093/carcin/bgp227",
language = "English (US)",
volume = "30",
pages = "1941--1948",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "11",

}

Chen, YC, Sosnoski, DM, Gandhi, UH, Novinger, LJ, Prabhu, KS & Mastro, AM 2009, 'Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer', Carcinogenesis, vol. 30, no. 11, pp. 1941-1948. https://doi.org/10.1093/carcin/bgp227

Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer. / Chen, Yu Chi; Sosnoski, Donna M.; Gandhi, Ujjawal H.; Novinger, Leah J.; Prabhu, K. Sandeep; Mastro, Andrea M.

In: Carcinogenesis, Vol. 30, No. 11, 04.12.2009, p. 1941-1948.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer

AU - Chen, Yu Chi

AU - Sosnoski, Donna M.

AU - Gandhi, Ujjawal H.

AU - Novinger, Leah J.

AU - Prabhu, K. Sandeep

AU - Mastro, Andrea M.

PY - 2009/12/4

Y1 - 2009/12/4

N2 - Breast cancer frequently metastasizes to the skeleton resulting in bone degradation due to osteoclast activation. Metastases also downregulate differentiation and the bone-rebuilding function of osteoblasts. Moreover, cancer cells trigger osteoblast inflammatory stress responses. Pro-inflammatory mediators such as interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), expressed by osteoblasts (MC3T3-E1) stimulated with human breast cancer cell (MDA-MB-231) conditioned medium, are pivotal to osteoclast activation and metastasis. Given that these genes are regulated by nuclear factor-κB (NF-κB), a redox-sensitive transcription factor, we hypothesized that selenium (Se) could abrogate the inflammatory response to metastatic breast cancer cells by modulating NF-κB. Caffeic acid phenethyl ester and parthenolide inhibited NF-κB activation, as seen by gel shift assays and immunoblotting for p65 in nuclear fractions, as well as decreased production of IL-6 and MCP-1. Supplementation of MC3T3-E1 with methylseleninic acid (MSA) (0.5 μM to 4 μM) reduced the activation of NF-κB leading to a decrease in IL-6, MCP-1, COX-2 and iNOS in response to MDA-MB-231 conditioned medium. Addition of MSA to osteoblasts for as little as 15 min suppressed activation of NF-κB suggesting that short-lived active metabolites might be involved. However, brief exposure to MSA also brought about an increase in selenoprotein glutathione peroxidase 1. In summary, our data indicate that the osteoblast response to metastatic breast cancer cells is regulated by NF-κB activation, which can be effectively suppressed by MSA either through short-lived active metabolites and/or selenoproteins. Thus, Se supplementation may prevent the osteoblast inflammatory response or dampen the vicious cycle established when breast cancer cells, osteoblasts and osteoclasts interact.

AB - Breast cancer frequently metastasizes to the skeleton resulting in bone degradation due to osteoclast activation. Metastases also downregulate differentiation and the bone-rebuilding function of osteoblasts. Moreover, cancer cells trigger osteoblast inflammatory stress responses. Pro-inflammatory mediators such as interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), expressed by osteoblasts (MC3T3-E1) stimulated with human breast cancer cell (MDA-MB-231) conditioned medium, are pivotal to osteoclast activation and metastasis. Given that these genes are regulated by nuclear factor-κB (NF-κB), a redox-sensitive transcription factor, we hypothesized that selenium (Se) could abrogate the inflammatory response to metastatic breast cancer cells by modulating NF-κB. Caffeic acid phenethyl ester and parthenolide inhibited NF-κB activation, as seen by gel shift assays and immunoblotting for p65 in nuclear fractions, as well as decreased production of IL-6 and MCP-1. Supplementation of MC3T3-E1 with methylseleninic acid (MSA) (0.5 μM to 4 μM) reduced the activation of NF-κB leading to a decrease in IL-6, MCP-1, COX-2 and iNOS in response to MDA-MB-231 conditioned medium. Addition of MSA to osteoblasts for as little as 15 min suppressed activation of NF-κB suggesting that short-lived active metabolites might be involved. However, brief exposure to MSA also brought about an increase in selenoprotein glutathione peroxidase 1. In summary, our data indicate that the osteoblast response to metastatic breast cancer cells is regulated by NF-κB activation, which can be effectively suppressed by MSA either through short-lived active metabolites and/or selenoproteins. Thus, Se supplementation may prevent the osteoblast inflammatory response or dampen the vicious cycle established when breast cancer cells, osteoblasts and osteoclasts interact.

UR - http://www.scopus.com/inward/record.url?scp=70849087652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70849087652&partnerID=8YFLogxK

U2 - 10.1093/carcin/bgp227

DO - 10.1093/carcin/bgp227

M3 - Article

C2 - 19759193

AN - SCOPUS:70849087652

VL - 30

SP - 1941

EP - 1948

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 11

ER -